Filter
Showing 1–40 of 42 results
Participants will be able to develop validation master plans, apply risk-based validation approaches, execute process and equipment qualification, manage documentation, and ensure inspection readiness aligned with global regulatory standards.
Coaching for Pharma Sales & Marketing Managers: Leadership Development & Performance Management Training
Participants will gain the ability to apply executive coaching using the GROW model, improve performance management, strengthen leadership development, enhance field effectiveness, and drive results through structured coaching.
Participants will develop the ability to understand the unique dynamics of pharmaceutical selling, manage territories effectively, and conduct impactful doctor interactions within limited consultation time. They will learn how to plan productive field calls, build professional relationships with healthcare professionals, support prescription generation, collaborate with chemists to ensure prescription fulfillment, and maintain professional conduct and compliance standards in pharmaceutical marketing.
Participants will develop the ability to lead and manage medical representative teams, analyze field reports and market intelligence, and drive territory-level business performance. They will learn how to coach team members through joint field work, support consultative selling, onboard new representatives effectively, manage vacant territories without business disruption, and use RCPA insights to guide strategy execution and improve market competitiveness.
Capital Investment Analysis: Pharma Strategy
Participants will develop the ability to evaluate pharmaceutical capital investments using financial modeling, clinical development insights, and regulatory risk assessment. They will learn how to assess project feasibility, estimate long-term value, and prioritize investment opportunities that support innovation, regulatory compliance, and sustainable business growth.
Participants will learn how pharmaceutical products are costed and priced across global markets while considering regulatory controls, reimbursement frameworks, and competitive dynamics. They will develop the ability to evaluate drug development costs, design value-based pricing models, and create international pricing strategies aligned with market access objectives and profitability goals.
Participants will gain a clear understanding of the stages involved in pharmaceutical drug discovery and development. They will learn how drug targets are identified, how potential drug candidates are screened and optimized, and how preclinical and clinical studies are designed to evaluate safety and efficacy. The program will also develop understanding of regulatory approval pathways, commercialization considerations, and emerging technologies that are transforming pharmaceutical research and development.
Internal & Supplier Audits for Quality in Pharma
Participants will gain the ability to design risk-based audit programs, conduct internal and supplier audits, evaluate findings, and implement effective CAPA systems to strengthen quality compliance.
Participants will gain the ability to prepare for regulatory inspections, evaluate compliance gaps, manage audit interactions, and develop corrective and preventive actions following regulatory observations.
Strategic Pharma Costing & Pricing Excellence
Participants will gain the ability to analyze pharmaceutical cost structures, design strategic pricing models for different markets, and balance profitability with regulatory and market access requirements.
FDA Audit Preparedness: Pharma Operations
Participants will gain the ability to assess audit readiness, identify compliance gaps, manage inspection processes, conduct internal audits, and implement corrective and preventive actions to sustain regulatory compliance.
Global Pharma Landscape: Strategy
Participants will gain the ability to analyze global pharma trends, evaluate business and operating models, assess market opportunities, and develop strategies to drive growth and competitive advantage.
Global (Non-US) Expansion Avenues for Indian Pharma
Participants will gain the ability to evaluate non-US pharmaceutical markets, understand regional regulatory pathways, design market entry strategies, and build partnerships that support sustainable international growth for Indian pharmaceutical companies.
Participants will develop the capability to manage end-to-end vaccine tender processes under UIP, ensure regulatory and documentation compliance, optimize bid strategies, mitigate procurement risks, and maintain supply continuity aligned with public health obligations.
Participants will develop the capability to manage end-to-end public procurement processes in the pharmaceutical sector with confidence and compliance. They will understand tender lifecycle management, regulatory alignment, risk mitigation, ethical safeguards, and contract governance—enabling them to execute procurement activities with transparency, accountability, and strategic effectiveness.
AI Tools Usage for Business Leaders
Participants will be able to navigate the AI tool ecosystem, confidently use leading AI platforms, design integrated AI-driven workflows, evaluate return on investment and implementation feasibility, deploy AI solutions across teams with structured governance, apply security and compliance best practices, and measure tangible business impact in terms of productivity, quality, and cost efficiency.
Prompt Engineering for Business LeadersÂ
Participants will be able to understand the fundamentals of AI and large language models, craft structured and high-impact prompts, apply advanced techniques such as chain-of-thought and persona-based prompting, integrate AI tools into business workflows for improved output quality, recognize AI limitations and apply human judgment appropriately, and implement ethical and secure AI practices within their organizations.
Participants will be able to conduct structured inspection readiness assessments, strengthen quality systems, manage regulatory interactions professionally, draft defensible observation responses, and implement corrective and preventive actions that withstand regulatory review.
PharmaConnect: Building Trust & Driving Sales
Participants will be able to develop trust-based engagement strategies with healthcare professionals, apply consultative selling techniques, leverage data-driven customer insights, align promotional activities with compliance standards, and execute targeted marketing initiatives to drive sustainable sales performance.
Participants will be able to manage end-to-end pharmacovigilance workflows efficiently, ensure high data quality standards, monitor compliance metrics and SLAs, optimize operational performance, and support audit and regulatory inspection readiness.
Competitive Intelligence for Pharma R&D
Participants will be able to build competitive intelligence frameworks, analyze competitor pipelines and patents, interpret regulatory and clinical trial trends, assess market entry risks, and integrate CI insights into product development and lifecycle strategy decisions.
Participants will be able to identify critical quality attributes (CQA), define critical process parameters (CPP), apply risk assessment and design of experiments (DoE), establish design space, and implement control strategies to ensure optimized and scalable pharmaceutical processes.
Participants will be able to apply ICH-based Quality Risk Management principles, conduct risk assessments using structured tools, integrate risk controls into quality systems, document risk decisions, and maintain a proactive risk-based compliance culture.
Participants will be able to develop qualification protocols, execute IQ, OQ, and PQ activities for laboratory equipment, apply risk-based approaches, ensure proper documentation, and maintain a validated state throughout the equipment lifecycle.
Participants will be able to implement the three-stage process validation lifecycle, define critical process parameters, design validation protocols, analyze process data statistically, and maintain continued process verification aligned with regulatory expectations.
Pharmaceutical Quality Management System
Participants will be able to design and manage a robust pharmaceutical QMS, integrate risk-based decision-making, strengthen deviation and CAPA processes, ensure documentation control, and maintain inspection readiness aligned with global regulatory standards.
Participants will be able to apply SPC tools, construct and interpret control charts, evaluate process capability indices, detect process trends, and integrate statistical monitoring into pharmaceutical quality and validation systems.
Participants will be able to apply GDP principles, implement ALCOA+ requirements, write structured and compliant technical documents, prevent documentation errors, and maintain inspection-ready records in accordance with global pharmaceutical regulations.
Participants will be able to implement risk-based stability strategies, manage global stability commitments, perform statistical shelf-life analysis, handle excursions and investigations, and ensure inspection readiness across product lifecycle stages.
Advanced Stability Operations for Pharmaceutical Quality
Participants will be able to design advanced stability protocols, conduct statistical trend analysis, manage deviations and temperature excursions, ensure data integrity compliance, and maintain inspection readiness throughout the product lifecycle.
Stability Operations for Pharmaceutical Quality
Participants will be able to develop compliant stability protocols, monitor stability programs, interpret data trends, determine shelf life, and handle deviations effectively while maintaining audit readiness.
GLP, GDP & Technical Writing for Pharmaceutical Quality
Participants will be able to apply GLP and GDP requirements accurately across laboratory and documentation workflows, produce clear and compliant technical documents, and evaluate records for data integrity and inspection readiness. They will strengthen their ability to prevent documentation-related deviations and respond confidently to regulatory scrutiny.
Pharma Analytical Method Validation (ICH Q2)
Plan and execute regulatory-compliant analytical method validation aligned with global expectations, reduce inspection observations linked to validation gaps, evaluate validation data to confirm method suitability and reliability, and maintain a validated state throughout the product life cycle.
Pharma Plant Maintenance Management
Participants will be able to Plan and execute structured maintenance activities to improve equipment reliability and uptime, reduce unplanned downtime through effective maintenance planning and response, maintain compliant documentation and inspection readiness, and control maintenance costs while supporting continuous pharma plant operations.
Participants will be able to learn the capability to align sales and marketing strategy, execute plans with discipline, prioritize high-impact actions, and drive measurable commercial outcomes.
Participants will be able to learn the capability to execute structured, value-driven in-clinic engagements, strengthen doctor relationships, improve brand influence, and drive consistent prescription outcomes.
Precision Selling for Pharmaceutical Sales
Participants will be able to learn the capability to apply precision selling strategies, tailor value propositions to stakeholder needs, and execute structured sales approaches that improve engagement and commercial outcomes.
Advanced Supply Chain Management for Pharmaceuticals
Participants will learn the capability to design and manage resilient pharmaceutical supply chains, improve planning accuracy, ensure regulatory compliance, and optimize service levels while controlling cost and risk.
Sustainable Waste Management in Pharma
Participants will learn to identify and control waste risks, implement sustainable waste management practices, and improve compliance while reducing disposal costs
Manage safety data to ensure accuracy, consistency, and compliance readiness while analyzing data to proactively identify risks and support sound regulatory decision-making, improving the quality and timeliness of safety-related regulatory reporting and reducing overall compliance risk through disciplined and effective data governance practices.
- 1
- 2